These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7704430)

  • 1. Cyclic AMP-mediated desensitization of D1 dopamine receptor-coupled adenylyl cyclase in NS20Y neuroblastoma cells.
    Black LE; Smyk-Randall EM; Sibley DR
    Mol Cell Neurosci; 1994 Dec; 5(6):567-75. PubMed ID: 7704430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
    Barton AC; Sibley DR
    Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity.
    Ventura AL; Sibley DR
    J Pharmacol Exp Ther; 2000 May; 293(2):426-34. PubMed ID: 10773012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
    Barton AC; Black LE; Sibley DR
    Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
    Zhang LJ; Lachowicz JE; Sibley DR
    Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
    Lin CW; Bianchi BR; Miller TR; Stashko MA; Wang SS; Curzon P; Bednarz L; Asin KE; Britton DR
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1022-9. PubMed ID: 8786531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
    Sasaki T; Kotera J; Omori K
    J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
    Lin CW; Miller TR; Witte DG; Bianchi BR; Stashko M; Manelli AM; Frail DE
    Mol Pharmacol; 1995 Jan; 47(1):131-9. PubMed ID: 7838121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.
    Lewis MM; Watts VJ; Lawler CP; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 1998 Jul; 286(1):345-53. PubMed ID: 9655879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of a slowly inactivating potassium current in striatal neurons by (+/-) 6-chloro-APB hydrobromide (SKF82958).
    Nisenbaum ES; Mermelstein PG; Wilson CJ; Surmeier DJ
    Synapse; 1998 Jul; 29(3):213-24. PubMed ID: 9635891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
    Chern Y; Lai HL; Fong JC; Liang Y
    Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
    Vortherms TA; Watts VJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization.
    Jiang D; Sibley DR
    Mol Pharmacol; 1999 Oct; 56(4):675-83. PubMed ID: 10496949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.